Algorithm IDs Patients at Risk of Post-MI Events

Oral Drug for Fabry Disease Approved Daily Headlines August 11, 2018 [Algorithm IDs Patients at Risk of Post-MI Events]( [Oral Drug for Fabry Disease Approved]( [Most Docs in Survey Report Symptoms of Burnout]( [iMedicalApps: This Week's Best New Products]( ['Everybody Is Starved for This Information': What We Heard This Week]( Recent Headlines [It's OK to Cry]( [One Word Docs Need to Know in Prison]( [Enrollment Rising in High-Deductible Plans]( [Regular Exercise Seems to Boost Mental Health]( CME/CE [HPV Catch-Up Vax Schedule More Effective in Younger Women]( CME/CE ADVERTISEMENT This Week's Survey [FDA: Too Much Time on Its Hands?]( [In addition to the usual approvals and recalls, the FDA has issued over 60 press announcements so far this summer -- including]([putting vaginal rejuvenation product makers]( on notice and issuing [43 new guidance documents]( on a single day. CME Spotlights [Optimizing Treatment for Patients With BRAF V600 Mutation u2013 Positive Metastatic Melanoma]( [Source:Axis Medical Education]( [Hepatocellular Carcinoma @Point of Care]( [Hepatocellular Carcinoma @Point of Care, clinical decision support tool for HCC diagnosis, treatment & management]( [Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists]( [Interview-style highlights from the u201cImmunotherapy and Breast Canceru201d session at the Society of Surgical Oncology 2018 Annual Cancer Symposium]( [Breast Cancer @Point of Care]( [clinical decision support tool for breast cancer diagnosis, Tx & management]( [Examining Recent Evidence Supporting DOAC Use in the Reduction of Thrombotic Events in Diverse Cardiovascular Patients]( [A clinical data review on the use of DOACs for vascular protection in patients with cardiovascular disease]( More of Today's Stories [Medicare to ACOs: Take Off the Training Wheels]( [March of the Mabs, Part 1: Keytruda in First-Line NSCLC Tx]( [FDA: Rhythm Method App Can Be Marketed for Contraception]( [Skeptical Cardiologist: Where Are My Generic Meds Made?]( [Patisiran Wins Two Firsts With FDA Approval]( [Pediatric Lupus: Different than in Adults]( [Opioid Use Rising in ADHD Patients on Stimulants]( [New T1D, Obesity Guidelines; DPP-4 Drug Risks; Soy Benefits (in Rats)]( [Frequent Basal Cell Cancers Sign of Broader Inherited Risk]( [Valsartan Recall Expanded, FDA Investigating Products from Outside China]( [Forming a Better Future]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [EverydayHealth] © Copyright 2018 Everyday Health, Inc. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com [terms of use]( and [privacy policy.]( The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address:{EMAIL} [Manage my e-mail settings]( | [Unsubscribe from "Daily Headlines"](lst=Daily%20Headlines) Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014